A phase Ib/II study of BBI608 combined with weekly paclitaxel in advanced pancreatic cancer.

被引：7
|
作者：
Bekaii-Saab, Tanios S.
Mikhail, Sameh
Langleben, Adrian
Becerra, Carlos
Jonker, Derek J.
Asmis, Timothy R.
Cote, Gregory Michael
Wu, Christina Sing-Ying
Kwak, Eunice Lee
Spira, Alexander I.
Braiteh, Fadi S.
Richey, Stephen Lane
Hume, Stephanie
Hitron, Matthew
Li, Chiang
机构：
[1] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Solove Res Inst, Columbus, OH 43210 USA
[2] St Marys Hosp, Westmount, PQ, Canada
[3] Texas Oncol, Baylor Sammons Canc Ctr, Dallas, TX USA
[4] Ottawa Hosp, Ctr Canc, Ottawa, ON, Canada
[5] Massachusetts Gen Hosp, Boston, MA 02114 USA
[6] Ohio State Univ, Ctr Comprehens Canc, Arthur G James Canc Hosp, Richard J Solove Res Inst, Columbus, OH 43210 USA
[7] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[8] Virginia Canc Specialists Res Inst, US Oncol Res, Fairfax, VA USA
[9] McKesson Specialty Hlth, US Oncol Network, The Woodlands, TX USA
[10] Texas Oncol, US Oncol Network, McKesson Specialty Hlth, Ft Worth, TX USA
[11] Boston Biomed Inc, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.196
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
196
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase Ib/II study of cancer stem cell inhibitor BBI608 administered with panitumumab in KRAS wild-type (wt) patients (pts) with metastatic colorectal cancer (mCRC) following progression on anti-EGFR therapy
    Ciombor, Kristen Keon
    Edenfield, William Jeffery
    Hubbard, Joleen Marie
    O'Dwyer, Peter J.
    Becerra, Carlos
    Larson, Tim
    Spira, Alexander I.
    Grothey, Axel
    Manoharan, Divya
    Li, Wei
    Li, Youzhi
    Borodyansky, Laura
    Li, Chiang
    Bekaii-Saab, Tanios S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] Survival analysis of a phase IB/II study of everolimus and metformin for patients with advanced cancer.
    Molenaar, Remco Jurriaan
    De Venne, Tim van
    Weterman, Mariette
    Mathot, Ron
    Klumpen, Heinz-Josef
    Riche, Dirk
    Wilmink, Johanna
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [43] Phase II study of docetaxel combined with cisplatin in advanced gastric cancer.
    Park, YS
    Park, KW
    Lee, J
    Kang, JH
    Kim, HY
    Park, JO
    Lee, SH
    Kang, WK
    Park, K
    Lee, SI
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 327S - 327S
  • [44] A phase II study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin in advanced esophageal cancer.
    Yoon, J.
    Hwang, J.
    Bae, W.
    Shim, H.
    Nam, T.
    Na, K.
    Chung, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [45] Phase II study of paclitaxel combined with vinorelbine in patients with advanced breast cancer
    Spano, JP
    Bouillet, T
    Boaziz, C
    Piperno-Neumann, S
    Brunel, P
    Hennebelle, F
    Amsalhem, P
    Brunet-Pommeyrol, A
    Kanoui, A
    Morin, F
    Breau, JL
    Morere, JF
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (03): : 317 - 321
  • [46] Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis
    Ishigami, H.
    Kitayama, J.
    Kaisaki, S.
    Hidemura, A.
    Kato, M.
    Otani, K.
    Kamei, T.
    Soma, D.
    Miyato, H.
    Yamashita, H.
    Nagawa, H.
    ANNALS OF ONCOLOGY, 2010, 21 (01) : 67 - 70
  • [47] Phase I/II study of cisplatin combined with weekly paclitaxel in patients with advanced non-small-cell lung cancer
    Yoshimura, N
    Kudoh, S
    Mukohara, T
    Yamauchi, S
    Yamada, M
    Kawaguchi, T
    Nakaoka, Y
    Hirata, K
    Yoshikawa, J
    BRITISH JOURNAL OF CANCER, 2004, 90 (06) : 1184 - 1189
  • [48] A phase II study of weekly paclitaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancer
    Inoue, A
    Usui, K
    Ishimoto, O
    Matsubara, N
    Tanaka, M
    Kanbe, M
    Gomi, K
    Koinumaru, S
    Saijo, Y
    Nukiwa, T
    LUNG CANCER, 2006, 52 (01) : 83 - 87
  • [49] Phase I/II study of cisplatin combined with weekly paclitaxel in patients with advanced non-small-cell lung cancer
    N Yoshimura
    S Kudoh
    T Mukohara
    S Yamauchi
    M Yamada
    T Kawaguchi
    Y Nakaoka
    K Hirata
    J Yoshikawa
    British Journal of Cancer, 2004, 90 : 1184 - 1189
  • [50] PHASE II STUDY OF WEEKLY INTRAVENOUS AND INTRAPERITONEAL PACLITAXEL COMBINED WITH S-1 FOR ADVANCED GASTRIC CANCER WITH PERITONEAL METASTASIS
    Ishigami, H.
    Kitayama, J.
    Kaisaki, S.
    Hidemura, A.
    Kato, M.
    Otani, K.
    Kamei, T.
    Soma, D.
    Miyato, H.
    Yamashita, H.
    Nagawa, H.
    ANNALS OF ONCOLOGY, 2009, 20 : 82 - 83
12345